Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1 May 24, 2022
Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors May 24, 2022
RSS